Consequently, GBM NOS cases were analysed in this study, a classification permitted by the WHO 2016 classification of central nervous tumors.48 In conclusion, we highlighted high IGF-1 blood levels and a low HGS as candidate factors for GBM risk. This evidence concerns the gene IGF1 and glioblastoma.